Jupiter Life Line Hospitals Ltd
Jupiter Life Line Hospitals Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Thane hospital expected to grow at inflation-linked rates at current capacity. Dombivli Hospital: Expected EBITDA breakeven by end of calendar year 2027 or early 2028 (about 2 years of operation).
From Jupiter Life Line Hospitals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Thane hospital expected to grow at inflation-linked rates at current capacity.
- Pune hospital has potential for growth via increased occupancy and inflation-linked price adjustments.
- Indore facility is in ramp-up phase with occupancy currently under 50%, expected to mature over 2-3 years; growth to come from improved occupancy and better case mix.
- Overall base business is expected to grow over 10% in the next 2 years driven by occupancy, case mix improvement, and inflationary price increases.
- New Dombivli hospital is ramping up with an EBITDA breakeven expected by end of 2 years of operation.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Jupiter Life Line Hospitals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR 500 crores capex deployed in FY26, including Dombivli hospital, BKC land payment, and ongoing Pune and Mira Road projects.
- Expansion plans include increasing bed capacity from 1,200 to nearly 2,900 beds in next few years, with around 1,700 new beds across 4 hospitals (Dombivli to BKC).
- BKC project: 400-bed quaternary care hospital on over 1 lakh square feet in a premium Mumbai location; land allotted and initial payment done; full land payment to be completed in this financial year.
- Mira Road project: Architectural drawings done, regulatory clearances underway, excavation expected to begin by year-end.
- Pune South hospital on track to open by calendar year 2028.
2 more points management made on capital expenditure plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Jupiter Life Line Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is undertaking a significant expansion cycle, adding approximately 1,700 new beds, which will take their long-term capacity to nearly 3,000 beds.
- The expansion projects include Dombivli (recently commissioned), Pune South (on track to open in calendar year 2028), Mira Road (architectural drawings completed, regulatory clearances underway, excavation expected by year-end), and BKC (a 400-bed quaternary care hospital in Mumbai).
- Land allotment for BKC has been received; prepossession formalities with MMRDA are ongoing.
- Capex for these projects is expected to be met through internal accruals and debt, with a self-imposed ceiling of 3 times EBITDA.
2 more points management made on order book & pipeline
Jupiter Life Line Hospitals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹388 Cr, net profit ₹50 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jupiter Life Lin's management said in earlier quarters
Others in Healthcare Services this season
- KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
- Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
- Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
Frequently Asked Questions
What were Jupiter Life Line Hospitals Ltd Q4 FY26 results?
Thane hospital expected to grow at inflation-linked rates at current capacity. Dombivli Hospital: Expected EBITDA breakeven by end of calendar year 2027 or early 2028 (about 2 years of operation).
What is Jupiter Life Line Hospitals Ltd share price analysis?
Jupiter Life Line Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 54.1 with a market cap of ₹10,351 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jupiter Life Line Hospitals Ltd planning capital expenditure?
INR 500 crores capex deployed in FY26, including Dombivli hospital, BKC land payment, and ongoing Pune and Mira Road projects.
Keep Jupiter Life Line Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.